Anti-Platelet Therapy and Aspirin Resistance - Clinically and Chemically Relevant?
Keywords: Anti-platelet; Arachidonic acid; Light transmittance aggregometry; Polymorphisms; Thienopyridines; Thromboelastography; acetylsalicylic acid; adenosine diphosphate; antiplatelet therapies; arachidonic acid; aspirin; atherosclerotic disease; atherothrombotic disease; cardiovascular risk; clopidogrel; coronary syndrome; cyclic-adenosine monophosphate (cAMP); cyclic-guanosine monophosphate (cGMP); cyclooxy-genase 1; cyclooxygenase enzyme; cyclopentyl-triazolopyrimidine; dipyridamole; electrode platelet ag-gregometry; fibrinogen receptors; glycoprotein; haematopoetic stem cell; haemostasis; liquid chromatography; megakaryocytes; mucosal hydrolysis; myocardial in-farction; myocardial infarction; plasma salicylic acid; platelet-glycoprotein; prasgruel; pre-cipitate stroke; relative risk reduction; resistance; salicyluric acid; thienopyridines; thromboxane; thromboxane A2
Document Type: Research Article
Publication date: 2010-12-01
- Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.